Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A form of meningitis caused by lymphocytic choriomeningitis virus. mice and other rodents serve as the natural hosts, and infection in humans usually occurs through inhalation or ingestion of infectious particles. Clinical manifestations include an influenza-like syndrome followed by stiff neck, alterations of mentation, ataxia, and incontinence. Maternal infections may result in fetal malformations and injury, including neonatal hydrocephalus, aqueductal stenosis, chorioretinitis, and microcephaly. (From Joynt, Clinical Neurology, 1996, Ch26, pp1-3)
Biomarker and diagnostic research for lymphocytic choriomeningitis has been reported in the published literature.
1 clinical trial registered. Interventions under study include other interventions. Research is primarily sponsored by academic and government institutions.
210 publications have been identified in PubMed for lymphocytic choriomeningitis. Research spans Basic Science / Preclinical (67%), Gene Therapy / Novel Therapeutics (8%), and Case Report / Case Series (8%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 141 | 67% |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 5:33 AM UTC
New treatment approaches |
17 |
8% |
Patient case studies | 16 | 8% |
Disease patterns and progression | 15 | 7% |
Research summaries | 8 | 4% |
Testing and diagnosis research | 7 | 3% |
Other research | 3 | 1% |
Clinical study results | 3 | 1% |
Abraham A (2026). [PMID: 42066794](https://pubmed.ncbi.nlm.nih.gov/42066794/). *Emerg Infect Dis*. [Epidemiology / Natural History]
Werner M (2026). [PMID: 41159916](https://pubmed.ncbi.nlm.nih.gov/41159916/). *J Exp Med*. [Basic Science / Preclinical]
Nousiainen A (2026). [PMID: 41595480](https://pubmed.ncbi.nlm.nih.gov/41595480/). *Genes (Basel)*. [Basic Science / Preclinical]
Hoyt-Miggelbrink AM (2026). [PMID: 41269210](https://pubmed.ncbi.nlm.nih.gov/41269210/). *Clin Cancer Res*. [Epidemiology / Natural History]
Wakutsu T (2026). [PMID: 42031293](https://pubmed.ncbi.nlm.nih.gov/42031293/). *Int J Infect Dis*. [Case Report / Case Series]
Ceri A (2026). [PMID: 42061916](https://pubmed.ncbi.nlm.nih.gov/42061916/). *Pediatr Rev*. [Review / Meta-Analysis]
Barnekow T (2026). [PMID: 41776660](https://pubmed.ncbi.nlm.nih.gov/41776660/). *J Occup Med Toxicol*. [Epidemiology / Natural History]
Flannery DD (2026). [PMID: 41863505](https://pubmed.ncbi.nlm.nih.gov/41863505/). *Emerg Infect Dis*. [Epidemiology / Natural History]
Lee Y (2026). [PMID: 42161271](https://pubmed.ncbi.nlm.nih.gov/42161271/). *Cell Rep Med*. [Basic Science / Preclinical]
Witwit H (2026). [PMID: 41659533](https://pubmed.ncbi.nlm.nih.gov/41659533/). *bioRxiv*. [Basic Science / Preclinical]